Skip to Main Content

Paper Details

Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.
Cancer Discov
214
2018
GEA, Gastroesophageal Adenocarcinoma, Gastroesophageal adenocarcinoma, cell, cell-free DNA, cfDNA, genomic biomarkers, metastatic lesions, metastatic tumors, oncogene, patients, primary, primary tumors, tumor
Author NameAffiliation
Rebecca NagyInc.
Kyoung-Mee KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Min Gew ChoiSamsung Medical Center, Sungkyunkwan University School of Medicine
Aaron R ThornerCenter for Cancer Genome Discovery, Dana-Farber Cancer Institute
Matthew DucarCenter for Cancer Genome Discovery, Dana-Farber Cancer Institute
Samuel S FreemanEli and Edythe L. Broad Institute
Samuel S FreemanEli and Edythe L. Broad Institute
Jeeyun LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
Adam J BassDana-Farber Cancer Institute
Adam J BassEli and Edythe L. Broad Institute
  • 1 - 10

Datasets

Release 1.2